Literature DB >> 12113560

Lacrimal function and ocular complications in patients treated with systemic isotretinoin.

B Bozkurt1, M T Irkeç, N Atakan, M Orhan, P O Geyik.   

Abstract

PURPOSE: To evaluate the effect on lacrimal function and ocular complications in patients with severe acne vulgaris during systemic treatment with 13-cis-retinoic acid (isotretinoin).
METHODS: Forty patients with acne vulgaris were treated with systemic isotretinoin at dosages of 0.5-1 mg/kg per day for two months. Full ophthalmologic examination, Schirmer I test, fluorescein break-up (BUT) and microbiological investigations of the conjunctival flora were done before, during the second month and at least one month after the end of the treatment.
RESULTS: The average Schirmer values before and after the treatment were 21.6 mm/5 minutes (SD +/- 7.01) and 18.48 mm/5 minutes (SD +/- 7.87) respectively. After the treatment BUT was less than 10 seconds in 50% of the patients and 55% had blepharitis. Subjective symptoms like dryness, itching and contact lens intolerance occurred in 42.5% and colonization of the conjunctiva by Staphylococcus aureus increased significantly during treatment (p= 0.031). All abnormal findings disappeared one month after the cessation of treatment. DISCUSSION: Isotretinoin causes signs and symptoms of dry eye, probably by reducing meibomian gland function, but ocular complications are generally not serious when low doses are used for a limited time, and are reversible after discontinuation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12113560     DOI: 10.1177/112067210201200316

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  9 in total

Review 1.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

2.  Structural and Functional Assessment in Patients Treated with Systemic Isotretinoin Using Optical Coherence Tomography and Frequency-Doubling Technology Perimetry.

Authors:  Berker Bakbak; Sansal Gedik; Bengu Ekinci Koktekir; Huseyin Guzel; Hilmi Cevdet Altınyazar
Journal:  Neuroophthalmology       Date:  2013-05-31

3.  Reduced ocular surface disease index (OSDI) scores in patients with isotretinoin treatment.

Authors:  Cagatay Caglar; Engin Senel; Emine Sabancilar; Mustafa Durmus
Journal:  Int Ophthalmol       Date:  2016-05-18       Impact factor: 2.031

Review 4.  Ocular complications associated with systemic medications used in allergy/immunology practice.

Authors:  Avinash Gurbaxani; Clare L Fraser; Simon E Skalicky; Peter McCluskey
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

Review 5.  Aging and dry eye disease.

Authors:  Juan Ding; David A Sullivan
Journal:  Exp Gerontol       Date:  2012-04-28       Impact factor: 4.032

6.  Evaluation of corneal topography and biomechanical parameters after use of systemic isotretinoin in acne vulgaris.

Authors:  Yusuf Yildirim; Onur Olcucu; Alper Agca; Cengiz Alagoz; Ali Demircan; Abdurrahman Basci; Ahmet Demirok; Zekayi Kutlubay
Journal:  J Ophthalmol       Date:  2014-11-30       Impact factor: 1.909

7.  Isotretinoin Impairs the Secretory Function of Meibomian Gland Via the PPARγ Signaling Pathway.

Authors:  Peng Zhang; Lei Tian; Jiayu Bao; Shang Li; Ao Li; Ya Wen; Jingyi Wang; Ying Jie
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

8.  Oral isotretinoin for acne vulgaris side effects on the ocular surface: Hyaluronic acid and galacto-xyloglucan as treatment for dry eye disease signs and symptoms.

Authors:  María Carmen Sánchez-González; Concepción De-Hita-Cantalejo; Concepción Martínez-Lara; José-María Sánchez-González
Journal:  Front Med (Lausanne)       Date:  2022-07-22

9.  Effect of retinoic acid on the nitrergic innervation of meibomian glands in rats.

Authors:  A Bolekova; D Kluchova; L Tomasova; N Hvizdosova
Journal:  Eur J Histochem       Date:  2012-11-30       Impact factor: 3.188

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.